openPR Logo
Press release

Technological Advancements to Influence Advances in Protein/Antibody Engineering Market Growth 2014-2020

09-14-2017 08:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Technological Advancements to Influence Advances

Antibodies and Proteins developed with new and advantageous functions and properties are known as engineering of protein and antibody. Protein engineering in specific can be defined as a process of developing valuable proteins and modification of antibodies to increase similarity or specificity is called as antibody engineering.

Antibody and protein engineering are used in applications such as, inflammatory disorders new therapeutic for treatment of diseases, protein purification, diagnostic and autoimmune. There are two approaches used for designing new antibodies and proteins which are directed evolution and the second is rational designing.
Antibodies occupied a huge market share of approximately around USD 30 billion in 2014 and the market shows huge signs of growth for the next five years. The market for antibody engineering is changing quickly due to novel technologies. Moreover, protein engineering offers flexibility in engineering and designing new and desirable antibodies is expected to be the major factor driving the growth of the market. In future the market has huge opportunities from rising prevalence of diseases such as cancer and increasing health care concerns.

Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-214

Beryllium, ProSci Incorporated, Precision Antibody, Fusion Antibodies, BioXcell, GenTarget Inc, Imagin AB, covalab, and IBL international are some of the major players participating in the market.This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product type and distribution channels.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Visit For TOC@ https://www.futuremarketinsights.com/toc/rep-gb-214

Regional analysis includes

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific
Japan
Middle East and Africa

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Technological Advancements to Influence Advances in Protein/Antibody Engineering Market Growth 2014-2020 here

News-ID: 715739 • Views:

More Releases from Future Market Insights

Zero Sugar Beverages Market to Reach USD 19.6 Billion by 2036 as Sugar Taxes, GLP-1 Adoption, and Portfolio Reformulation Reshape the Beverage Industry
Zero Sugar Beverages Market to Reach USD 19.6 Billion by 2036 as Sugar Taxes, GL …
The global zero sugar beverages market is entering a structural growth phase, projected to surge from USD 5.0 billion in 2026 to USD 19.6 billion by 2036, reflecting a robust CAGR of 14.7%. According to Future Market Insights (FMI), the acceleration is being driven by expanding sugar taxation frameworks, GLP-1 medication-led health awareness, and the strategic conversion of mainstream beverage portfolios toward zero-sugar formulations. In 2024, the World Health Organization reinforced
Global Tannase Market to Reach USD 757.7 Million by 2036 as Enzymatic Processing Gains Regulatory and Strategic Momentum
Global Tannase Market to Reach USD 757.7 Million by 2036 as Enzymatic Processing …
The global tannase market is projected to grow from USD 447.0 million in 2026 to USD 757.7 million by 2036, reflecting a steady CAGR of 5.4%, according to Future Market Insights (FMI). The expansion is structurally anchored in the rising adoption of enzymatic processing across tea, wine, fruit juice, and functional beverage manufacturing, where tannase plays a critical role in tannin hydrolysis to enhance clarity, taste, and shelf stability. Momentum intensified
Global Coffee Extracts Market to Reach USD 2.4 Billion by 2036 as Liquid Concentrates Redefine Value Chain Dynamics
Global Coffee Extracts Market to Reach USD 2.4 Billion by 2036 as Liquid Concent …
The global coffee extracts market is projected to expand from USD 1.6 billion in 2026 to USD 2.4 billion by 2036, registering a steady CAGR of 4.4%, according to insights by Future Market Insights (FMI). Growth is increasingly driven by liquid coffee concentrate formats, with Gen Z and millennial consumers reshaping consumption patterns toward cold, customizable, and ready-to-mix beverages. The structural demand base remains strong. The International Coffee Organization reported global
Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million by 2036 as Sustainable Specialty Brewing Gains Momentum
Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million …
The global olive stone coffee and beverage roasts market is entering a high-growth decade, fueled by sustainability innovation and evolving specialty coffee culture. Valued at USD 510 million in 2026, the market is projected to reach USD 1,620 million by 2036, expanding at a compelling CAGR of 11.5%. As consumers increasingly seek beverages that combine sustainability, functionality, and distinctive taste, olive stone-based roasting solutions are transitioning from niche experimentation to structured

All 5 Releases


More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage